Latest Articles
7MM endometriosis diagnosed prevalent cases to hit 2.8 million in 2034 - Healthcare Asia Magazine
7MM endometriosis diagnosed prevalent cases to hit 2.8 million in 2034 Healthcare Asia Magazine
Published: June 11, 2025, 3:52 a.m.
GPs across Wales trained to spot endometriosis earlier - Wrexham.com
GPs across Wales trained to spot endometriosis earlier Wrexham.com
Published: June 11, 2025, 3:23 a.m.
New Smart Pad Technology Detects Health Markers in Menstrual Blood, Aiming to Close Gaps in Women's Healthcare - MSN
New Smart Pad Technology Detects Health Markers in Menstrual Blood, Aiming to Close Gaps in Women's Healthcare MSN
Published: June 10, 2025, 10:59 p.m.
‘Push for answers’: Bindi Irwin joins forces with UN to call for action on endometriosis - Women's Agenda
‘Push for answers’: Bindi Irwin joins forces with UN to call for action on endometriosis Women's Agenda
Published: June 10, 2025, 10:53 p.m.
OnlyFans' Annie Knight 'Feeling Better' After Hospitalization - okmagazine.com
OnlyFans' Annie Knight 'Feeling Better' After Hospitalization okmagazine.com
Published: June 10, 2025, 5:07 p.m.
PRM Welcomes Dr. Amro Elfeky to Enhance Endometriosis Care in Houston and Dallas - The Manila Times
PRM Welcomes Dr. Amro Elfeky to Enhance Endometriosis Care in Houston and Dallas The Manila Times
Published: June 10, 2025, 1:47 p.m.
Daiichi announces first subject dosing in Enhertu trial for endometrial cancer - Yahoo
Daiichi announces first subject dosing in Enhertu trial for endometrial cancer Yahoo
Published: June 10, 2025, 9:47 a.m.
Women’s longevity, heart health and more in focus at Hong Kong summit - South China Morning Post
Women’s longevity, heart health and more in focus at Hong Kong summit South China Morning Post
Published: June 10, 2025, 9:15 a.m.
Daiichi announces first subject dosing in Enhertu trial for endometrial cancer - Clinical Trials Arena
Daiichi announces first subject dosing in Enhertu trial for endometrial cancer Clinical Trials Arena
Published: June 10, 2025, 9:06 a.m.
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer - Physician's Weekly
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer Physician's Weekly
Published: June 10, 2025, 6:31 a.m.
Link copied to clipboard!